How to Treat Hydronephrosis: From Diagnosis to Recovery

Expert guidance on treating hydronephrosis, detailing initial management, obstruction removal, temporary decompression, and full recovery.

Treatment for hydronephrosis depends entirely on what is causing the kidney to swell and how long the blockage has been in place. In mild cases caused by a small kidney stone, the swelling may resolve on its own with medication and fluids. In severe or infected cases, emergency drainage through a stent or a tube placed directly into the kidney can be lifesaving. The condition itself is not a disease but a sign that urine is backing up, and the real work lies in finding and fixing whatever is blocking its path.

Why Kidneys Swell in the First Place

Hydronephrosis literally means “water in the kidney.” It happens when urine cannot drain properly from the kidney into the bladder, causing the renal pelvis to balloon outward. The obstruction can sit anywhere along the urinary tract, from the junction where the kidney meets the ureter all the way down to the bladder outlet. In a study of 233 patients, kidney or ureteric stones accounted for more than half of all cases, with the largest share of those stones lodged at the junction where the ureter enters the bladder. Reflux (urine flowing backward from the bladder) caused about 7% of cases, and narrowing at the junction between the kidney and ureter accounted for roughly 4%.

Other common culprits include an enlarged prostate pressing on the urethra, tumors that compress a ureter from outside, blood clots, and scar tissue from prior surgery or radiation. In pregnant women, the growing uterus can lean on the ureters, and hormonal changes relax the smooth muscle that normally keeps urine moving. That kind of pregnancy-related swelling is so common it has its own name: gestational hydronephrosis.

How Hydronephrosis Gets Diagnosed

Ultrasound is the usual first step. It is fast, radiation-free, and good at revealing a swollen renal pelvis. But ultrasound has real limitations: the measurement of the kidney’s front-to-back pelvic diameter shifts depending on how hydrated you are, how full your bladder is, and even whether you are lying down or standing up. That variability means an ultrasound can overestimate or underestimate severity, especially in borderline cases.

When doctors need a clearer picture, they typically turn to a CT scan with contrast. CT is the gold standard for finding stones, mapping their size and location, and checking for tumors or other structural problems. A diuretic renal scan using a tracer called MAG-3 adds functional information: it shows how well the kidney is actually filtering and draining, which helps distinguish between a kidney that looks swollen but drains fine and one that is truly obstructed. That distinction matters because a dilated pelvis does not always mean ongoing damage.

Grading how bad the swelling is turns out to be surprisingly contentious among specialists. Multiple scoring systems exist, and none of them fully agrees with the others. The most widely used systems in pediatrics, for instance, can lump together kidneys with minimal thinning of the tissue and kidneys that look like near-empty sacs under the same grade, making it hard to know from the grade alone who needs surgery and who can safely wait. Reliability between different clinicians reading the same images is only moderate at best. In practice, this means treatment decisions usually combine the imaging grade with blood work, symptoms, and the clinical picture rather than relying on a single score.

Researchers are also investigating kidney-injury biomarkers in urine and blood that could flag damage earlier than traditional tests. Molecules like NGAL, kidney injury molecule 1, and cystatin C rise when kidney tissue is under stress from a blockage and may eventually help doctors decide when to intervene more precisely.

When Emergency Drainage Is Needed

Not every case of hydronephrosis requires urgent action. A mild backup from a small stone, in a patient who is not feverish and has normal kidney function, can often be managed with pain control, hydration, and close monitoring. But if the blockage is paired with infection, the situation becomes a medical emergency. Urine trapped behind a blockage is an ideal breeding ground for bacteria, and the resulting condition, sometimes called pyonephrosis or obstructive urosepsis, can turn life-threatening fast. Immediate drainage of the blocked kidney is the priority for removing the source of infection and is directly tied to the patient’s outcome.

Emergency drainage can also save a kidney that might otherwise need to be removed. When an infected kidney is drained early with a percutaneous nephrostomy tube, it buys time for the infection to clear and the kidney to recover, allowing definitive treatment of the underlying problem to happen later under safer conditions.

Nephrostomy Tube Versus Ureteral Stent

When urgent decompression is needed, there are two main routes. A percutaneous nephrostomy (PCN) involves inserting a thin tube through the skin of the back directly into the kidney, guided by ultrasound or fluoroscopy. A retrograde ureteral stent (a flexible tube threaded up from the bladder into the kidney) achieves the same goal from the opposite direction. Both work, and a systematic review and meta-analysis found no significant difference in how well each method controls infection or clears the obstruction.

The differences show up in side effects and quality of life. In one prospective trial, nephrostomy succeeded in 100% of patients, while stent placement failed in about 20% and required conversion to nephrostomy. Patients with stents needed more pain medication, and their quality of life actually worsened over the course of diversion. Nephrostomy patients, by contrast, saw gradual improvement. A separate meta-analysis confirmed that PCN patients reported less blood in the urine and less painful urination, though they tended to stay in the hospital a bit longer.

In practice, the choice often comes down to the clinical scenario. Stents are placed in a procedure room or operating room and leave nothing outside the body, which many patients prefer. Nephrostomy tubes require an external bag for urine collection and ongoing wound care, but they are more reliably placed in severely infected or anatomically difficult cases. The evidence suggests the decision can reasonably rest on the urologist’s judgment and the patient’s preference when both options are technically feasible.

Medical Expulsive Therapy for Stones

If a stone is small enough and the patient is stable, medication may coax the stone out without any procedure at all. This approach, called medical expulsive therapy, uses drugs that relax the smooth muscle of the ureter to help the stone pass naturally. Alpha-blocker medications are the most commonly used and have the strongest supporting data. Evidence suggests they improve the rate of stone passage while reducing pain episodes, the need for narcotic painkillers, and trips to the emergency room. Professional guidelines endorse this strategy for appropriately selected patients, typically those with smaller stones in the lower ureter who are not showing signs of infection or kidney failure.

Surgical Correction for Structural Blockages

When the obstruction is not a stone but a structural problem, such as a narrowing where the kidney meets the ureter (called ureteropelvic junction obstruction, or UPJO), surgery is often needed. The standard procedure is a pyeloplasty, which removes the narrowed segment and reconnects the healthy portions. Done robotically, this surgery has success rates above 96% in both first-time and repeat cases, with a median hospital stay of about one day for pediatric patients.

For men whose hydronephrosis stems from an enlarged prostate blocking the bladder outlet, treating the prostate itself is the definitive fix. A case of bilateral ureteral obstruction caused by benign prostatic enlargement was resolved by placing temporary stents in both ureters and then performing a transurethral resection of the prostate; the patient was discharged three days later and had comfortable urination with normal kidney function at his follow-up.

Managing Malignant Obstruction

Cancer-related ureteral blockages present a distinct challenge. Tumors of the cervix, bladder, prostate, or colon can squeeze a ureter shut from the outside, and standard plastic stents sometimes buckle under the external pressure and fail to hold the ureter open. Options include placing two stents side by side (tandem stents), using solid metallic stents, or choosing metal-mesh stents designed to resist compression. In a comparative study, metallic stents had a one-year patency rate of about 78%, compared with roughly 61% for standard polymeric stents. When stenting is not feasible, a long-term nephrostomy tube draining into an external bag may be the only option to preserve kidney function while cancer treatment continues.

Hydronephrosis During Pregnancy

Mild hydronephrosis in pregnancy is so common it is considered physiological rather than pathological. The enlarging uterus leans on the ureters, and the hormone progesterone relaxes the ureteral muscle, slowing drainage. The right side is affected more than the left because of the uterus’s natural rightward tilt. These changes are a consequence of increased kidney blood flow (which rises by up to 75% near term), the hormonal effects, and the mechanical compression.

Most pregnant women need no treatment at all; the swelling resolves after delivery. For the minority who develop severe symptoms or infection, ureteral stenting is one option, but there are practical drawbacks. Stents placed during pregnancy may need to stay in for months, and they can encrust or cause significant discomfort. A case report documented post-stent encrustation in a postpartum woman that complicated removal, underscoring the importance of early detection and timely stent retrieval. A simpler first-line strategy for symptomatic pregnant patients is postural drainage: lying on the unaffected side with the hips elevated uses gravity to shift the uterus off the compressed ureter.

Prenatal Hydronephrosis in Babies

When a fetus is found to have a swollen kidney on a prenatal ultrasound, the natural reaction is alarm. But antenatal hydronephrosis is transient in close to half of all cases and resolves on its own before or shortly after birth. What makes the finding more concerning is the presence of low amniotic fluid levels or additional kidney or structural anomalies, both of which point to a more serious underlying problem.

A full fetal bladder can make the kidney pelvis appear more dilated than it truly is, leading to overdiagnosis. To get around this, researchers have proposed using a hydronephrosis index that divides the pelvic diameter by the fetal bladder volume, which corrects for the confounding effect of a distended bladder. In practice, most babies with mild prenatal hydronephrosis are followed with repeat ultrasounds after birth. Intervention becomes necessary only if the swelling worsens, kidney function declines, or the child develops urinary infections.

What Determines Whether a Kidney Recovers

The single biggest factor in kidney recovery is time. Classic experimental work established that if an obstruction is relieved within about two weeks, the kidney can regain normal structure and function. The longer the blockage persists, the slower and less complete the recovery. In human patients with kidney failure from obstruction, those whose symptoms lasted 25 days or less had a dramatically better chance of recovery, around 79%, compared with about 32% for those symptomatic longer. The thickness of the remaining kidney tissue also mattered: patients with a cortical thickness above 16.5 millimeters recovered at a rate of roughly 95%, versus about 38% for those with thinner tissue.

These findings reinforce a practical point: if you have symptoms suggesting a urinary blockage, such as flank pain, difficulty urinating, or blood in the urine, prompt medical attention can make the difference between a kidney that bounces back and one that sustains permanent damage. Thinning of the kidney tissue increases with age at the time of surgery, which means older patients who delay treatment face a double penalty: longer exposure to the obstruction and tissue that may already be less resilient.

Postobstructive Diuresis and Other Surprises After Relief

Relieving the blockage does not always mean the drama is over. Once a severe obstruction is cleared, the kidneys sometimes go into overdrive, producing very large volumes of dilute urine in a phenomenon called postobstructive diuresis. In most cases, this flushing is self-limiting and the body rebalances on its own within a day or two. In severe cases, though, the massive urine output can lead to dehydration, dangerous drops in sodium or potassium, and, if left unmanaged, even death. Monitoring fluid balance and electrolytes in the hours and days after decompression is standard practice for patients who had bilateral or prolonged obstruction.

Stent-related discomfort is another common surprise. Many patients find that living with a ureteral stent is more unpleasant than the original problem, reporting urinary urgency, frequency, flank pain during urination, and blood in the urine. Research into better stent materials and designs, as well as medications that calm the bladder’s response, is ongoing. Stents left in too long can also encrust with mineral deposits, a process that makes removal more difficult and risky. Among commonly used stent materials, silicone tends to resist encrustation best, though no current material eliminates the problem entirely.

Long-Term Follow-Up and Chronic Kidney Disease

Even after successful treatment, hydronephrosis can leave a lasting mark on kidney function. Many patients who had significant obstruction go on to develop some degree of chronic kidney disease and benefit from regular follow-up with a nephrologist. That follow-up typically involves periodic blood tests to track kidney function, blood pressure monitoring, and, when warranted, medications that protect the kidneys from further damage. Reducing cardiovascular risk factors is especially important in this group, because kidney disease and heart disease feed into each other. Evidence supports blood pressure control and the use of medications like ACE inhibitors and SGLT2 inhibitors for kidney protection in patients with chronic kidney disease following obstruction.

If you had a temporary stent or nephrostomy tube placed, follow-up appointments to remove it on schedule are not optional. A forgotten stent is a stent that encrusts, potentially creating a new stone and a new obstruction on top of the original problem. For patients who needed long-term or permanent stenting due to cancer or chronic conditions, periodic stent exchanges are part of the ongoing care plan. The treatment path for hydronephrosis rarely ends at the procedure itself; what you do afterward shapes whether the kidney stays healthy for the long run.